Skye Bioscience, Inc. SKYE
NASDAQ · United States · Health Technology
$1.60-0.01 (-0.62%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -2.16 | -2.04 | -5.9% | $0 | — | -23.3%$4.33→$3.32 |
| Q1 2026 | 2026-05-11 | -2.56 | -2.32 | -10.3% | — | — | -5.7%$6.90→$6.51 |
| Q4 2025 | 2026-03-10 | -2.95 | -2.45 | -20.4% | — | — | -0.4%$5.79→$5.77 |
| Q3 2025 | 2025-11-10 | -2.56 | -2.64 | +3.0% | — | — | -4.6%$12.24→$11.68 |
| Q4 2024 | 2025-03-20 | -2.33 | -2.28 | -2.2% | — | — | — |
| Q2 2024 | 2024-08-09 | -1.60 | -1.56 | -2.6% | — | — | — |
| Q1 2024 | 2024-05-10 | -1.44 | -1.28 | -12.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.